The effects of VEGF, a major regulator of vascular endothelial cells, have generally been studied using cells cultured on mechanically stiff polystyrene. However, vascular disease is associated with changes in blood vessel wall stiffness over a range that is significantly softer than tissue culture plastic. In this study, we explored how VEGF-induced calcium signaling in endothelial cells is modulated by the stiffness of the underlying substrate over a physiological relevant range (4-125 kPa). An image analysis tool was developed to allow us to quantitatively examine the response of individual cells, clusters of cells, and overall cell populations. We used this tool to identify distinctions in cells that responded most strongly to VEGF treatment as a function of stiffness. that we have used to help uncover outcomes that are hidden within the average. The ability to selectively identify highly VEGF responsive cells within a population may lead to a better understanding of the specific phenotypic characteristics that define cell responsiveness, which could provide new insight for the development of targeted anti-and pro-angiogenic therapies.
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Introduction:
As humans and animals age, the vasculature of the body stiffens. The degree of stiffening correlates with cardiovascular morbidity, which can in turn lead to further stiffening pathologies such as atherosclerosis 1, 2 . The turnover of and alterations in the extracellular matrix (ECM) underlying the cells of the vasculature is largely responsible for this change. Disruption of the matrix metalloproteinase (MMP) balance and increased advanced glycation end products (AGE) contributes to increased collagen deposition, cross-linking, and subsequent stiffening of the vasculature [3] [4] [5] [6] . How much the stiffness is altered in aging and disease is highly variable and may also depend on where the measurement was made.
While healthy vessels range from about 2.5-50 kPa, diseased regions of vessels have stiffness ranges from about 10-200 kPa [7] [8] [9] [10] , and for comparison, tissue culture polystyrene stiffness is in the gigapascal range 11 .
Various cell types respond to substrate stiffness differently. The fate of stem cells has been shown to vary depending on the ECM stiffness 12 . Confluent endothelial cells, without the aid of any growth factors, show increased permeability and proliferation as a function of the stiffness of the ECM on which they are cultured 13, 14 . Cells remodel and spread more extensively on stiffer substrates and the actin cytoskeleton increases its organization. However, substrate stiffness is not an independent stimulus to the cell as we have recently shown that the response of vascular smooth muscle cells to substrate stiffness is dependent on the specific matrix proteins present 14 and others have shown dramatically different endothelial cell responses to stiffness depending on specific source of the cells 15 . Cells have also been
shown to take on the size and shape of the matrix beneath them 16 . An increase in protein ligand or stiffness results in a corollary increase in certain integrin proteins within mature focal adhesions 14, 17 .
The ECM not only dictates cell adhesion properties, but also is a storage depot for growth factors.
Fibronectin, a protein up-regulated in pathological conditions such as at sites of endothelial cell dysfunction, is well characterized as having a heparin binding domain where numerous growth factors can bind and potentially interact with cells [18] [19] [20] . Vascular endothelial growth factor (VEGF), a major proangiogenic protein, binds to fibronectin with a high affinity 18, 21, 22 . Prior studies have linked β1 integrin protein to matrix-bound VEGF and prolonged downstream signaling 23 . VEGF-receptor 2 activation, the functional pathway responsible for much of VEGF biology, has been shown to cross react with several downstream integrin pathways, further suggesting a connection between the two receptor systems 24 .
VEGF has been one of the most studied vasoactive agents as its potential to stimulate new vasculature and healing in areas damaged by age, wounds, or disease is widespread, yet attempts to use VEGF clinically have been unsuccessful likely due to a lack of complete understanding of its mechanism and effectors [25] [26] [27] . VEGF interacts with two main receptor types, VEGFR1 and VEGFR2. VEGFR1, has a high affinity for VEGF, storing the growth factor, blocking its interaction with VEGFR2 28 . VEGFR2 is responsible for downstream angiogenic properties such as vessel survival, migration, permeability, and proliferation. It signals through traditional tyrosine kinase receptor dimerization and activation of downstream effectors including ERK (proliferation), AKT (survival), and calcium flux (permeability) 28 .
Endothelial cells have highly variable protein and epigenetic profiles based on the vascular bed of origin and even within an individual vessel. For instance, at any point an endothelial cell can be quiescent, or be involved in the angiogenesis process 29, 30 . An angiogenically active population of endothelial cells will send out an individual tip cell that is highly responsive to VEGF to initiate the migration and growth of a new capillary as directed by a matrix-bound VEGF gradient. Stalk cells, resting behind the tip cell, are also responsive to VEGF, but they proliferate rapidly to form the new vessel lumen 31, 32 . A better understanding of how to switch quiescent cells to angiogenic cells and vice versa could provide a pathway towards new treatment paradigms.
To test our hypothesis that ECM stiffness selectively modulates VEGF-endothelial cell activation, we developed a new analytical tool, which is able to uniquely access individual cell VEGF-calcium response and identify heterogeneous trends within a seemingly homogenous cell population. We found that response varied with stiffness in a complex manner. A large proportion of VEGF-treated cells were non-responsive or showed a slow, steady increase in activity, whereas a smaller subpopulation of highly responsive cells spiked rapidly and returned to a lower activation level. Response magnitude and rate, independent of stiffness depended on VEGF concentration. The highly responsive cells maintained a distinct shape indicating that primed, highly VEGF responsive, cells may have a shape-dependent association. We present data that unmasks trends and populations previously hidden within a simple average.
Results:
The mechanical environment in which cells grow must be considered in a biological context.
Growth factor availability and interactions vary with mechanical stiffening. To more fully appreciate how local mechanical properties impact growth factor activity, we devised an experimental system that allows cellular signaling kinetics to be monitored quantitatively using polyacrylamide gels of defined stiffness.
Moreover, we developed an analytical approach that distinguishes the averaged response of a population of cells from the response of individual cells and clusters of cells. This approach will provide insight into the full range of growth factor activities within a biologically relevant context.
Our stiffness model consists of tunable polyacrylamide gels that are covalently linked to glass coverslips. The surfaces of the gels were exposed to a coverslip coated with Fn allowing passive transfer to occur during polymerization. Larger quantities of Fn were needed to functionalize the softer gels to produce gels that contained the same concentration of Fn on the surface (Figure 2A ). The range of stiffness (4 -125 kPa) was selected to represent reported values for normal and diseased vascular tissue in vivo [7] [8] [9] [10] . In preliminary studies we attempted to extend this range to lower and higher stiffness values but observed alterations in the cells such that comparisons would involve multiple variables under these conditions. To verify that the ECM environments remained comparable after several days of cell exposure across the 4-125 kPa stiffness range, we imaged the Fn matrix on the three stiffness substrates after four days in culture and found no visible differences in the Fn fiber structure or density ( Figure 2B ).
Additionally, we observed that the BAECs produce a varied ECM, which includes type 1 collagen ( Figure   2B ) after 3 days in culture. Thus, the mechanically tunable gel system provides a template to culture endothelial cells on in order to study the influence of matrix stiffness on cell behavior.
To study the cellular signaling response to VEGF and ECM stiffness, we measured the calcium response in endothelial cells cultured on gels of varying stiffness using live-cell imaging 33 . The individual cell analysis was conducted using a MATLAB script that is described in the methods section ( Figure 1 ). Analysis of 52 runs from multiple days, substrate stiffness, and treatment conditions indicate that the segmentation algorithm correctly identified cells 87% of the time.
The built-in functionality of MATLAB provided a way to quantify the average pixel intensities of every cell identified by the algorithm. Additionally, the major axis, minor axis, and area of each cell were quantified. Differences in the size and shape of the cells were analyzed on the various stiffness ECMs ( Table 1 ). The changes in cell size, although significant, are not particularly large indicating that the BAECs are not especially sensitive to stiffness-modulated cell spreading under these conditions. We and others have shown that the specific ECM proteins present and the type of cells tested dictate the cell spreading response to stiffness 15, 34 .
Numerous studies have investigated the various responses of endothelial cells to VEGF treatment.
Many of these studies compile average readouts from a large population of cells using methods to measure mRNA and protein expression, or to measure cell responses such as cell proliferation, migration and tube formation. While these studies have defined important VEGF activities, it is likely that averaging the response over large populations of cells results in loss of pertinent information. To address these possibilities, while also exploring how substrate stiffness influences VEGF activity, we compared population base and individual cell analysis of the endothelial cell calcium response to VEGF to determine if ECM stiffness modulates VEGF responsiveness. We found minimal calcium mobilization in response to low doses of VEGF and attenuation of the response at high doses of VEGF treatment ( Figure   3A ). Maximal responses were observed with 5 ng/ml on 4 kPa ECM (1.5 and 1.7 fold over the 25 and 125 kPa samples, respectively) and 10 ng/ml on the 25 kPa ECM (1.6 and 1.8 fold over the 4 kPa samples and 125 kPa samples, respectively). The cellular response to VEGF on the 125 kPa ECM was insensitive to VEGF concentration, with the response showing little variation across the dose range analyzed.
To examine the dynamics of the average calcium response in greater detail, we computed a variety of outputs including maximal calcium response, rate of activation, and deactivation rate (parameters defined in Figure 4 ) for each of the conditions (VEGF dose and ECM stiffness) tested (Table 2 ). The kinetics and maximal responses of the three clusters are compiled in Table 3 . The response of the bulk cluster was much more sustained than that of the high responders and the average response as indicated by the lower activation and deactivation rates and increased maximum time. For concentrations of VEGF below 25 ng/ml, cells on the 25 kPa and 125 kPa ECMs within the largest (bulk) cluster reached maximal response at the end of the treatment period ( Figure 7 ). Activation and deactivation times, regardless of cluster, were almost always inversely correlated with concentration of VEGF. Activation time varied with VEGF dose suggesting that the rate of activation is likely a reflection of the time it takes for a threshold level of activated VEGF-VEGF receptor complexes to be reached, instead of being based on the intrinsic time required for signal processing. Faster activation rates also correlated with higher maximum intensity values in almost all samples (except the average cluster on the 125 kPa ECM). The deactivation rate did not correlate with VEGF dose or ECM stiffness.
After segregating the cells into clusters based on normalized cell intensity, we wanted to explore how much variation remained in these after their extraction. We computed the coefficient of variation (COV; standard deviation/mean), for a variety of different parameters ( Figure 8 ). We did not find any statistically significant differences among stiffness or VEGF concentration, but we did find that certain variables were much more predictable than others. We found that the maximum time and the overall area of the cells were the least variable (lower COV) as compared to the highly variable activation time and maximum values. When the high responders and bulk responders were analyzed separately we found significant differences in activation time, maximum time, and maximum values between these clusters.
The differences were most notable for the high responder category, which has significantly reduced variability as compared to the bulk responders or to all the cells together. This suggests that cells in the high responder cluster are behaving in a more unified manner than the rest of the cell population, indicating that they may posses a characteristic that is predictive of VEGF responsiveness.
To determine if there are specific phenotypic characteristics among cells within a larger population that might indicate VEGF responsiveness, we compared specific cell shape parameters of the high responders to those of the bulk responders. Specifically, we compared the average cell area, and the major and minor axis lengths of the cells within the bulk responder cluster to those in the high responder cluster ( Figure 9 ). At low concentrations of VEGF (1 ng and 5 ng/ml) we detected a significant decrease in overall cell area of the high responders. We also found a reduction in the minor and major axis lengths of the high responders in the 1 ng/ml VEGF treatment groups ( Figure 9 A-C). The differences were no longer statistically significant in the groups that were treated with higher VEGF concentrations (10 and 25 ng/ml), and, as such, we observed that the differences in cell size between the two clusters were significantly reduced with increased VEGF concentration ( Figure 9 D-F).
Variations in VEGFR2 levels on cells as a function of substrate stiffness and cell size/shape could provide a mechanism to explain the differences in VEGF responsiveness. To determine if VEGFR2 levels change under these conditions, flow cytometry analysis of our cells cultured on various stiffness substrates was performed. We observed consistent levels of VEGFR2 regardless of stiffness ( Figure 10 ).
Additionally, the forward scatter, a measure of relative cell size and the intensity of VEGFR2 staining only had a minor positive correlation with each other (average 0.55). Thus as cell size increases there may be a proportional increase in total VEGFR2 expression, indicating that receptor density does not vary with cell size.
Discussion:
Phenotypic changes in endothelial cells in response to stiffness have been well documented 15, [35] [36] [37] , but little is known about how these changes impact intracellular signaling in response to external stimuli.
In the present study we show that VEGF-induced calcium signaling within endothelial cells is modulated by stiffness. These changes in signaling were largely reflected by alterations in the magnitude of the cell response. The cells maintained the same number of local maxima, and the percentage of cells being activated was similar across the stiffness range evaluated. Interestingly, responses were attenuated in the cells on the stiffest substrates. Previous studies have shown specific integrin heterodimer expression increases with matrix stiffness 14, 38 , suggesting a molecular mechanism by which cell-ECM engagement may be modulated by substrate stiffness. The mechanism of action of VEGF has been linked to the state of the extracellular matrix in a number of studies. Prior studies have assessed the ability of VEGF to interact with a variety of different ECM proteins including fibronectin 18, 19, 39 . Binding of VEGF to the matrix can extend downstream MAPK activation 22, 23 . In prior studies testing the binding ability of VEGF to various different ECM proteins, including type 1 collagen, VEGF bound with the greatest affinity to VEGFR2 signaling has been shown to coordinate with integrin signaling, and physical association of VEGFR2 with integrins has been suggested to modulate VEGF internalization and signaling kinetics 23, 28, [41] [42] [43] [44] [45] [46] . Thus, the intimate connection between the VEGF system and the process by which the cell interacts with the ECM may provide the basis for how VEGF signaling is modulated by ECM stiffness.
The attenuation of VEGF signaling that we observed in cells on the stiffest matrices may relate to the inability of the body to repair severely stiffened atherosclerotic blood vessels as well as the ability of newly developing soft tissues and tumors to actively recruit the development and growth of new vasculature. The stiffness of diseased vessels can vary up to an order of magnitude, which can lead to dramatically altered cell phenotypes [7] [8] [9] . Primary cell cultures lose up to 40% of their microenvironment specific phenotypes when they are cultured on plastic 30, 47 . Thus, the use of cell culture substrates at more physiologically relevant stiffness may provide important insight into how cell response is controlled in vivo.
While our study revealed interesting distinctions in the response of endothelial cells to VEGF as a function of stiffness when averaged over the entire population, the power of our study was largely in the individual cell analysis. Prior studies have looked at endothelial cell heterogeneity 29, 30, 47, 48 . P53 protein levels oscillate with set frequency and amplitude after cell exposure to γ-radiation, but there is a concentration dependent persistent response after UV radiation 49 . In PC12 cells, epidermal growth factor induces transient ERK activation while nerve growth factor leads to a sustained ERK response, a response that may be essential for cell differentiation [50] [51] [52] . In other instances, the amplitude from baseline, not the timing, dictates the specific ERK activation 53 . Uncovering the role of signal dynamics in endothelial cells could provide further insight into activation and targets for inducing/eliminating angiogenesis.
The dynamics of calcium signaling have been shown to control individual cell fates. For example, transient spikes in calcium have been shown to activate different transcription factors than a sustained response 54, 55 . It is well known that VEGF activates calcium signaling through both phospholipase C IP 3 -mediated release of intracellular calcium stores and TRPC3 and TRPC6 cation channels, but individual cell calcium response to VEGF has not been explored previously. We used a nonbiased hierarchical clustering scheme to identify several distinct clusters. Analyzing these responses together as the bulk response and comparing it to remaining cells, or high responders, yielded some interesting findings. We found that temporal speed is a sensor for concentration. In general, as the concentration of VEGF increased, regardless of stiffness, we found a shortening of the time until activation and time until the overall maximum point was reached. This finding indicates that activation time is not fully dependent on the reaction time, but instead likely reflects a threshold reaction whereby signaling is activated when a specified concentration of ligand-receptor complexes is reached.
While parsing out the individual cell response we were able to determine that endothelial cells on the softest substrates (4 kPa) were most sensitive to VEGF treatment. The percentage of high responders was altered by stiffness, but not in any discernable pattern. For example, in the 1 ng/ml VEGF condition, 19% of cells on the 4 kPa substrates, 29% of cells on the 25 kPa substrates and 35 % of the cells on the 125 kPa substrates were high responders. Despite those differences, the average of maximums of the high responders from each run in the 4 kPa condition was greater than that of either remaining stiffness indicating the active cells that were responding were stimulated to a greater extend than in the other stiffness conditions. High responders for the 4 kPa condition also had a greater difference between their high responders average maximum and bulk responders average maximum than in the other conditions. These trends were clear when looking at individual cell responses, but were not detectable within the average of the population-based responses.
Cells on our 25 kPa constructs (our model for a moderately aged vessel) had the greatest overall maximum and activation rate compared to any other condition, but this occurred at a moderate VEGF dose. It is possible that the integrin connection, or another biological pathway, is limiting the ability of the cells to respond to VEGF as stiffness increases. At the maximal VEGF dose tested, the difference in average maximum values of the high responders and bulk responders with substrate stiffness was lost.
This indicates that the stiffness limitations to VEGF dose are overcome.
Our clustering analysis revealed some interesting conclusions regarding variability within the overall cell population. We found that ~40% of the cells did not respond at all regardless of stiffness and VEGF dose. In addition to the non-responders there were an additional 15-35% of cells that showed a slow muted response. The high responder group had a rapid, large, and transient increase in calcium release. Two distinct patterns of VEGF responsiveness that we detected have been reported previously.
The Chen group reported two main clusters of traction force strain curves after VEGF treatment of endothelial cells 56 . They treated endothelial cells with a range of VEGF doses and found that most cells exhibited no response or a gradual increase in strain energy when treated with lower concentrations (10 ng/ml) of VEGF, but as VEGF dose increased (up to 100 ng/ml), the number of cells displaying an initial spike of strain energy after VEGF treatment increased 56 . The high responders in our data set as an average have a peak response at 10 ng/ml, but closer examination of the heatmaps ( Figure 5) shows that even though the average responses decreased at 25 ng/ml, there are more of the high responders exhibiting spikes as indicated by the increase in yellow lines. The similarities in dynamics and quantity of cells responding between our study and the Chen study may indicate that our high responders represent cells that have a migratory phenotype.
Only a fraction of the cells within the population responded strongly to VEGF suggesting that there may be differences in receptor levels or phenotypic characteristics that define these "VEGFsensitive" cells. We investigated the idea that VEGFR2 levels may be altered by stiffness but discovered that the levels remained constant regardless of stiffness. We further explored the size and shape of the cells within the various clusters to determine if these characteristics were linked to responsiveness.
Previous studies indicated that cell shape itself can feedback and influence the stiffness of the actual cells on the matrix 36 . Others have noted that alterations in endothelial cell shape are linked to the cellular release of chemotactic factors and the consequent recruitment of monocytes in in vivo models 57 . Indeed, classic studies using in vitro 2D polystyrene cell culture systems identified distinct morphological phenotypes of tip cells with long thin lamellipodia compared to more bulky stalk cells 31 . In the present study we observed that the high responders are statistically smaller than the bulk responders at low doses of VEGF. The alteration in size was largely due to decreased length of the minor axis indicating a narrowing of the cells. At higher doses of VEGF, there was no significant difference in size between high responders and low responders. Together, these findings indicate that at low doses of VEGF high responders were morphologically different from bulk responders, but at high doses of VEGF, cells of any shape or size could overcome a threshold allowing them to become a high responder. 59 . Thus it is possible that our distinct subgroups are reflective of these two sub-types of endothelial cells 31 . In this paradigm, the high responders take on the tip cell, leading edge, migratory role and the bulk responders act as stalk cells with a slow steady VEGF activation.
Materials and Methods:
Forty percent acrylamide and two percent bis-acrylamide solutions, and ammonium persulfate were purchased from BioRad (Hercules, CA). Phosphate buffered saline (PBS) (10x) was purchased from Gibco (Grand Island, NY). Gluteraldhyde was purchased from Sigma-Aldrich (Natick, MA). Human fibronectin was from Millipore (Billerica, MA). TEMED and coverslips were acquired from Fisher Scientific (Pittsburgh, PA). Total fibronectin antibody 610077 was from BD Biosciences (San Jose, CA), and TMB Microwell Peroxidase was from KPL (Gathersburg, MD). Cell culture reagents, including fetal bovine serum (FBS), calf serum, trypsin EDTA, Dulbecco's modified Eagle's medium, penicillin streptomycin cocktail, and L-glutamine, were purchased from Corning (Tewksbury, MA). Fn-depleted fetal bovine serum was made using gelatin-agarose (Sigma-Aldrich (Natick, MA)) as previously 
Gels:
Various stiffness polyacrylamide gels (4, 25, and 125 kPa) were produced using a sandwich methodology developed previously 14, 61 . Briefly, glass coverslips were cleaned with 0.1 N NaOH and washed with distilled water. After drying, coverslips were coated with various concentrations of fibronectin (Fn) protein, depending on the corresponding stiffness, in order to produce a uniform density of Fn on the surface of all gels. After drying the coverslips under vacuum at 4°C, they were washed and dried a second time. A second set of coverslips was treated with 3-aminopropyltrimethoxysilane, allowed to dry, washed several times with distilled water and then treated with 0.5% glutaraldehyde for thirty minutes. Glutaraldehyde was removed, coverslips were washed several times with distilled water, and they were stored in water until ready for use. Polyacryalamide gel mixture (0.1 ul/mm 2 ) was added to each 3-Aminopropyltrimethoxysilanecoated coverslip 14, 61 . A corresponding Fn coated coverslip was added to the top and gels were allowed to polymerize under vacuum at 4°C for 1 hr at which point the Fn on the top coverslip was successfully transferred, without the aid of NHS-ester, to the covalently linked gel below. Gels were washed in PBS, quenched in sterile 3% BSA-PBS for 1 hr and then washed again with PBS prior to cell seeding.
Gel Protein Verification:
Fn-ELISAs were conducted to verify that the density of Fn on the gel surfaces was consistent across the tested stiffness conditions. Known concentrations of Fn were adsorbed to polystyrene surfaces that were the same size of the gels in order to establish standard curves. Gels were fixed for 20 minutes at 4°C in 4% paraformaldehyde in PBS. After fixation, samples were washed in tris buffered saline (TBS) and then incubated in 3% bovine serum albumin (BSA) TBS for 1 hr to block non-specific sites. After blocking, gels were incubated with BD total Fn primary antibody for 1 hour at a 1:10000 dilution in 3% BSA-PBS, then washed with TBS prior to treatment with a Jackson Laboratories HRP linked secondary antibody to mouse at 1:5000 for 1 hour in 3% BSA-PBS. Finally, samples were washed several times in 0.1% TBS-Tween and TBS prior to 3,3',5,5'-tetramethylbenzidine (TMB) substrate reaction. The absorbances of multiple samples from each well were measured using a 96-well
OptiMax plate reader (Molecular Devices). Background A550 readings were subtracted from sample A450 readings. Fibronectin levels were calculated based on the standard curve.
Cell Culture: Bovine Aortic Endothelial Cells (BAECs) (passage 6-16) were used for all experiments.
Cells were maintained in DMEM supplemented with 10% calf serum, 1% penicillin/streptomycin cocktail and 1% L-glutamine. BAECs were prepared by washing several times with phosphate buffered saline (PBS) followed by trypsinization of cell sheets. Trypsin was inhibited with DMEM supplemented with 10% Fn-depleted serum. Cells were seeded at 21,000 cells/cm 2 in the Fn-depleted serum. After 24 hrs in culture, the cells were washed once with PBS and fresh 0.5% fibronectin depleted serum was added for the remaining 24 hrs prior to experimentation. All experiments were conducted with cells at 50-70%
confluence to maintain consistent levels of cell-cell contacts, which are known to be able to inhibit VEGF activation and cell-ECM specific responses.
Matrix Staining: After 3 days in culture, BAEC cells were fixed with 4% paraformaldehyde PBS for 20 minutes on ice. Solutions were removed, cell layers were washed with PBS 3x prior to permeabilization with 0.1% triton-x 100. Cells were washed again 3x with PBS and then blocked with 3% BSA-PBS for 1 hour at RT. BSA-PBS was exchanged for primary antibody (Type 1 Col 1:100 or Fn 1:250) in BSA-PBS for 1 hour at RT. Prior to the addition of secondary antibody the primary antibody was removed with multiple washes with PBS. Secondary antibody (mouse Alexa A488) was added for 1 hour at RT.
Samples were washed 3x more with PBS prior to mounting with Vectashield onto slides. Cells were imaged on a Zeiss 700 confocal.
Flow Cytometry Analysis:
Cells were grown on gels functionalized with fn as described above. 
Post Imaging Analysis:
Segmentation: MATLAB cell segmentation was conducted using a method modified from a Mathworks Engineering blog 62 . Briefly, to provide the best average cell representation, the first 50 frames of the treatment were added together. Contrast was enhanced and cell areas were enhanced to optimize perimeter identification. After identifying individual perimeters, the cell nuclei, or minima of each cell were identified. Marked areas containing both a nuclei and a cell perimeter were counted as individual cells 33 . Figure 1 provides step-by-step description of this critical step in analysis.
Data analysis:
The software script was written to address many population based outputs and single cell analysis parameters. For all analysis, the segmented cell outlines were utilized to break each image into individual cells that were quantified using a pre-defined MATLAB function, "regionprops". The regionprops function is able to assess cell area, pixel intensities, centroid location, and a variety of other parameters. Utilizing this ability, we were able to calculate the individual cell intensity during treatment and correct it for its own individual background as averaged throughout the first 50 frames of control analysis. This correction minimizes the effect of any cells that may be pre-actived or "primed" to respond prematurely prior to treatment.
Normalized intensity:
The normalized intensity is the average intensity in which each cell is further normalized (divided by) its own individual background. The values are represented as percentages. Our population based cell traces represent at least 7-11 biological replicates. Any run where the average normalized maximums were two times greater or less than the maximum of the average normalized intensity for all other runs was pre-excluded from the analysis. 
Statistical Analysis:
All data presented were generated from 7-11 biological replicates for each stiffness and VEGF dose treatment condition (12 conditions in total). Approximately 80 cells were analyzed from each sample at ~800 separate treatment time points. The coefficient of variation (absolute mean from a run/standard deviation) for each treatment was averaged together. For the coefficient of variation and any other condition in which we were considering the statistical significance between treatment groups we utilized a student's two-sided T-test for unequal variance with alpha set at 0.05. For experiments in which we were comparing groups of data within one experiment (i.e., high responders to bulk responders from the same experimental run), we used a one sided pairwise t-test to test for significance change in size at alpha 0.05.
Conclusion:
We found that endothelial cell responsiveness to VEGF could be tuned to the stiffness of the ECM resting Figure 4 . There is no significant difference between the variation in cell areas, but there is significant differences between most of the subtypes of the remaining categories. Significance (α < 0.05) in reference to the all cells category, is marked with bars. Figure 9 : Cell size is different between clusters. A-C: Average values for cell sizes of bulk responders and high responders +/-SEM. Significance (always α < 0.05) is defined as a difference between the high and bulk responder categories for each run (7-11 per stiffness and 3 different stiffness) in a pairwise onetailed T-test. D-F: The average differences between bulk and high responders for each cell size parameter. Significance is defined for differences between concentrations using an unequal variance, two-tailed T-test. A and D: Area, B and E: Major Axis, C and F: Minor Axis Figure 10 : VEGFR2 levels are constant with stiffness. VEGFR2 levels were measured using flow cytometry with an antibody to total VEGFR2. Briefly, cells were suspended from gels, counted, fixed and permeabilized and stained with primary antibody for 1 hour and fluorescent secondary antibody for 30 minutes. Cells were washed and transferred to cell strainer tubes for BD FACS Caliber analysis. Median values reflect the median fluorescent intensity of VEGFR2 staining after correction for secondary only background. The median fluorescence intensity values are provided for cells isolated from gels of each stiffness as well as for cells where the primary VEGFR2 antibody was excluded (secondary only control). Table 1 : Descriptive information regarding the geometry and size of cells analyzed. Area is the quantitative area of the region segmented, it is a true value, not an approximation based on a relative diameter. For each region, an artificial ellipse with the same second moments of the cell is created over the segmented cell. The major axis length and minor axis length are reflective of this ellipse. The number of cells per run is represented with +/-standard deviation. The remaining characteristics are given as +/-standard error of the mean. All areas and relative cell lengths were significant when compared to each other, except for no significant difference between the minor axis length of the 4Kpa and 125 kPa samples. Table 2 : Descriptive information on the cell traces provided in Figure 3 . Information on overall trace maximum, activation time, deactivation time, and the rate of activation and deactivation is provided for each normalized intensity trace. These values are demonstrated on Figure 3B . Activation rate is the slope of the best-fit linear approximation from the activation time (the first point over 3% normalized intensity) through to the overall maximum. Deactivation rate occurs from the overall maximum time to the end of each run. The percentage maximum number of cells activated for each run is also included. Table 3 : Descriptive information on the cell traces provided in Figures 5 and 6 . Information on maximum, activation time, deactivation time, and the rate of activation and deactivation is provided for each normalized intensity race. The information is separated by both concentration and the average of all traces, the bulk cluster, and the cells not included in the bulk cluster (ie the high responders). 
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